Rights and permissions
About this article
Cite this article
Glaxo maintains ‘ondansetron safe’. Inpharma Wkly. 867, 20 (1992). https://doi.org/10.2165/00128413-199208670-00046
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199208670-00046